Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

50%

3 of 6 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

Phase 4

1(50.0%)

N/A

1(50.0%)

2Total

Phase 4(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT02070614Completed

Association of CYP3A4 rs2242480 With Sufentanil Plasma Concentration and PCA Consumption

Role: lead

NCT01186159Phase 4Completed

The Correlation of COX-2 Expression in Human Polymorphonuclear Leukocytes/Macrophages (PMNL/MP) and Postoperative Pain

Role: lead

NCT01950078Completed

The Possible Correlations Between the Genes Related to Pain Sensation and the Pain Sensitivity in the General Population

Role: lead

NCT01750047Completed

A Epidemiological Survey of Preoperative Pain Perception and Postoperative Pain in Chinese Population

Role: lead

NCT01507493Completed

The Impact of SCN9A Gene Polymorphism on Individual Pain Perception in the General Population

Role: lead

NCT01618942Not ApplicableCompleted

To Measure Pain Perception With Electronic Pressure Algometer of Different Size Probes : a Healthy Subjects Research

Role: lead

All 6 trials loaded